News

Filter

Current filters:

AstraZenecalesinurad

Positive Ph III data for AstraZeneca’s lesinurad in gout patients

17-11-2014

Anglo-Swedish pharma major AstraZeneca has presented positive top-line results of two pivotal Phase III…

allopurinolAnti-Arthritics/RheumaticsAstraZenecaInflammatory diseaseslesinuradPharmaceuticalResearch

AstraZeneca to showcase inflammation/ autoimmunity pipeline at ACR

AstraZeneca to showcase inflammation/ autoimmunity pipeline at ACR

11-11-2014

Anglo-Swedish pharma major AstraZeneca, with its global biologics R&D subsidiary MedImmune, will present…

anifrolumabAnti-Arthritics/RheumaticsAstraZenecaBiotechnologybrodalumabInflammatory diseaseslesinuradMavrilimumabMedImmuneResearchSifalimumabUSA

AstraZeneca reports positive results from lesinurad trial for gout

AstraZeneca reports positive results from lesinurad trial for gout

13-08-2014

Anglo-Swedish drug major AstraZeneca has said its Phase III trials of lesinurad in combination with xanthine…

AstraZenecaEuropeGastro-intestinalslesinuradPharmaceuticalResearchSymptomatic gout

AstraZeneca lesinurad meets Ph III goal in gout patients

AstraZeneca lesinurad meets Ph III goal in gout patients

16-12-2013

Anglo-Swedish drug major AstraZeneca has released positive top-line results from LIGHT, a Phase III…

Anti-Arthritics/RheumaticsAstraZenecaInflammatory diseaseslesinuradPharmaceuticalResearch

AstraZeneca to acquire Ardea Bio for $1.26 billion

23-04-2012

In line with its stated policy of making strategic, rather than mega, acquisitions, Anglo-Swedish drug…

Anti-Arthritics/RheumaticsArdea BiosciencesAstraZenecaBiotechnologyGenito-urinarylesinuradMergers & AcquisitionsPharmaceutical

COMPANY SPOTLIGHT

Menarini

Back to top